Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor-induced Osteomalacia (TIO)”

7 trials

Showing 7 of 7 results

Early research (Phase 1)UnknownNCT04689893
What this trial is testing

Application of 68Ga-DOTA-TATE and 68Ga-DOTA-JR11 PET/CT in the Diagnosis and Evaluation of TIO

Who this might be right for
Tumor-Induced Osteomalacia
Peking Union Medical College Hospital 50
Not applicableAvailableNCT03775187
What this trial is testing

Expanded Access to Burosumab

Who this might be right for
X-linked HypophosphatemiaTumor-Induced Osteomalacia
Kyowa Kirin Co., Ltd.
Not applicableActive Not RecruitingNCT04783428
What this trial is testing

Tumor-induced Osteomalacia Disease Monitoring Program

Who this might be right for
Tumor-induced Osteomalacia (TIO)
Ultragenyx Pharmaceutical Inc 23
Not applicableStudy completedNCT00099762
What this trial is testing

Catheterization to Locate Mesenchymal Tumors in Patients With Tumor-Induced Osteomalacia or Oncogenic Osteomalacia

Who this might be right for
OsteomalaciaNeoplasms
National Institute of Dental and Craniofacial Research (NIDCR) 45
Not applicableLooking for participantsNCT07366099
What this trial is testing

Al18F-NOTA-LM3 PET/CT in Patients With TIO

Who this might be right for
Tumor-Induced Osteomalacia
Peking Union Medical College Hospital 40
Testing effectiveness (Phase 2)Study completedNCT02304367
What this trial is testing

Study of Burosumab (KRN23) in Adults With Tumor-Induced Osteomalacia (TIO) or Epidermal Nevus Syndrome (ENS)

Who this might be right for
Tumor Induced Osteomalacia (TIO)Epidermal Nevus Syndrome (ENS)
Kyowa Kirin, Inc. 17
Post-approval studies (Phase 4)Study completedNCT05357573
What this trial is testing

Study to Assess the Safety, Pharmacokinetics and Efficacy of KRN23 in Adult Chinese Patients With TIO

Who this might be right for
Tumor-Induced Osteomalacia (TIO)
Kyowa Kirin Co., Ltd. 9

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation